Cyanobacterial type I CRISPR-Cas systems: distribution, mechanisms, and genome editing applications
Yongjiu Zhang,
No information about this author
Shuxiao Yang,
No information about this author
Zhaofeng Li
No information about this author
et al.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 27, 2025
Cyanobacteria,
renowned
for
their
photosynthetic
capabilities,
serve
as
efficient
microbial
chassis
capable
of
converting
carbon
dioxide
into
a
spectrum
bio-chemicals.
However,
conventional
genetic
manipulation
strategies
have
proven
incompatible
with
the
precise
and
systematic
modifications
required
in
field
cyanobacterial
synthetic
biology.
Here,
we
present
an
in-depth
analysis
endogenous
CRISPR-Cas
systems
within
genomes,
particular
focus
on
Type
I
systems,
which
are
most
widely
distributed.
We
provide
comprehensive
summary
reported
DNA
defense
mechanisms
mediated
by
current
applications
genome
editing.
Furthermore,
offer
insights
future
these
context
editing,
underscoring
potential
to
revolutionize
biology
approaches.
Language: Английский
Efforts to Downsize Base Editors for Clinical Applications
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2357 - 2357
Published: March 6, 2025
Since
the
advent
of
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)
system
in
gene
editing
field,
diverse
CRISPR-based
tools
have
been
developed
for
treating
genetic
diseases.
Of
these,
base
editors
(BEs)
are
promising
because
they
can
carry
out
precise
at
single-nucleotide
resolution
without
inducing
DNA
double-strand
breaks
(DSBs),
which
pose
significant
risks
genomic
instability.
Despite
their
outstanding
advantages,
clinical
application
BEs
remains
challenging
due
to
large
size,
limits
efficient
delivery,
particularly
adeno-associated
virus
(AAV)-based
systems.
To
address
this
issue,
various
strategies
explored
reduce
size
BEs.
These
approaches
include
truncating
nonessential
domains
and
replacing
bulky
components
with
smaller
substitutes
compromising
efficiency.
In
review,
we
highlight
importance
downsizing
therapeutic
applications
introduce
recent
advances
size-reduction
strategies.
Additionally,
ongoing
efforts
overcome
other
limitations
BEs,
providing
insights
into
potential
improving
vivo
editing.
Language: Английский
Advancements in CRISPR-Cas-Based Strategies for Combating Antimicrobial Resistance
Ruiting Zhang,
No information about this author
Qi Zhou,
No information about this author
Siying Huang
No information about this author
et al.
Microbiological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 128232 - 128232
Published: May 1, 2025
Language: Английский
Research Progress and Application of Miniature CRISPR-Cas12 System in Gene Editing
Qiangbing Xuan,
No information about this author
Junjie Wang,
No information about this author
Yingbin Nie
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12686 - 12686
Published: Nov. 26, 2024
CRISPR-Cas
system,
a
natural
acquired
immune
system
in
prokaryotes
that
defends
against
exogenous
DNA
invasion
because
of
its
simple
structure
and
easy
operation,
has
been
widely
used
many
research
fields
such
as
synthetic
biology,
crop
genetics
breeding,
precision
medicine,
so
on.
The
miniature
CRISPR-Cas12
an
emerging
genome
editing
tool
recent
years.
Compared
to
the
commonly
CRISPR-Cas9
CRISPR-Cas12a,
unique
advantages,
rich
PAM
sites,
higher
specificity,
smaller
volume,
cytotoxicity.
However,
application
Cas12
proteins
methods
improve
efficiency
have
not
systematically
summarized.
In
this
review,
we
introduce
classification
summarize
structural
characteristics
type
V
cleavage
mechanism
five
proteins.
gene
animals,
plants,
microorganisms
is
summarized,
strategies
are
discussed,
aiming
provide
reference
for
further
understanding
functional
engineering
modification
system.
Language: Английский
Efficient, compact, and versatile: Type I‐F2 CRISPR‐Cas system
Shengsheng Ma,
No information about this author
Senfeng Zhang,
No information about this author
K. Liu
No information about this author
et al.
mLife,
Journal Year:
2024,
Volume and Issue:
3(3), P. 384 - 386
Published: Sept. 1, 2024
Language: Английский
Research Progress on the Mechanism and Application of the Type I CRISPR-Cas System
Peihong Yang,
No information about this author
Shuai Zhang,
No information about this author
Debao Hu
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12544 - 12544
Published: Nov. 22, 2024
The
CRISPR-Cas
system
functions
as
an
adaptive
immune
mechanism
in
archaea
and
bacteria,
providing
defense
against
the
invasion
of
foreign
nucleic
acids.
Most
systems
are
classified
into
class
1
or
2,
with
further
subdivision
several
subtypes.
primary
distinction
between
2
lies
assembly
their
effector
modules.
In
systems,
complex
consists
multiple
proteins
distinct
functions,
whereas
is
associated
a
single
protein.
Class
account
for
approximately
90%
repertoire
categorized
three
types
(type
I,
type
IV,
III)
12
To
date,
various
have
been
widely
employed
field
genetic
engineering
essential
tools
techniques
genome
editing.
Type
I
remain
valuable
resource
developing
sophisticated
application
tools.
This
review
provides
comprehensive
characteristics,
mechanisms
action,
applications
well
transposon-associated
offering
effective
approaches
insights
future
research
on
subsequent
development
systems.
Language: Английский